A Pharmacokinetic Study in Healthy Non-elderly Male and Female Volunteers to Investigate the Effect of Food on the Pharmacokinetics of YM178
Phase of Trial: Phase I
Latest Information Update: 16 Jul 2013
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder; Urination disorders
- Focus Pharmacokinetics
- Sponsors Astellas Pharma
- 06 Oct 2009 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
- 06 Oct 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 06 Sep 2009 New trial record